Xia et al. showed that SFN specifically inhibited hypoxia-induced glycolysis by decreasing HIF-1α protein levels and inhibiting nuclear translocation of HIF-1α, resulting in a blocked proliferation of bladder cancer cells in vivo and in vitro (Xia et al. 2019). The gene discussed is HIF1A; the disease is urinary bladder cancer.